Generalized Anxiety Disorder Adjunct Study

Completed · Phase 3 · Has a placebo group

Conditions studied: Anxiety, Anxiety Disorders, Anxiety Neuroses, Anxiety States

In brief

This study is being carried out to see if extended release quetiapine fumarate (Seroquel®XL) when added to standard selective serotonin reuptake inhibitor (SSRI) / serotonin-norepinephrine reuptake inhibitor (SNRI) therapy is effective and safe for the treatment of Generalized Anxiety Disorder in patients with partial or no response to SSRI/SNRI alone or in combination with a benzodiazepine, and if so, how it compares with placebo

Key facts

Study ID
NCT00534599
Run by
AstraZeneca
People needed
409
Starts
2007-08-01
Expected to finish
2008-09-01
Last updated by the study team
2011-04-14

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.